Related Experiment Video
Updated: Jul 17, 2026
09:13
Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
Randomization and baseline transmission in vaccine field trials.
1IMS/UERJ and Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil. stru@procc.fiocruz.br
Epidemiology and Infection
|February 13, 2007
Summary
Randomization in vaccine trials ensures balanced groups but may not eliminate bias from unmeasured factors like infection exposure. Baseline transmission levels must be considered for comparable trial results.
Area of Science:
- Epidemiology
- Clinical Trials
- Biostatistics
Background:
- Randomized trials aim for unbiased treatment assignment.
- Randomization ensures covariate balance on average.
- However, it does not guarantee unbiased effect estimates.
Purpose of the Study:
- To investigate confounding by infection exposure in randomized vaccine trials.
- To examine the limitations of randomization in controlling for unmeasured covariates.
- To assess the comparability of vaccine trial estimates based on baseline transmission.
Main Methods:
- Utilized a simple model of biological efficacy.
- Extended concepts of comparability and collapsibility.
- Analyzed Phase III randomized, placebo-controlled vaccine field trials.
Main Results:
- Infection exposure can act as a confounder in randomized vaccine trials.
- Randomization has limits in controlling for unmeasured confounding variables.
- Estimates from trials with differing baseline transmission are not directly comparable.
Conclusions:
- Unmeasured covariates, such as infection exposure, can bias vaccine efficacy estimates.
- Explicit control for baseline transmission is necessary for comparable randomized vaccine trial results.
- The generalizability of vaccine efficacy findings depends on accounting for transmission dynamics.
Related Concept Videos
01:13Randomized Experiments
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...